Dr. Kenneth Davis
Mount Sinai (New York)
When Davis was named CEO in 2003, Mount Sinai was a medical center with two hospitals and a school of medicine. During his tenure, he has transformed the organization into an integrated health system that includes eight hospitals, more than 400 outpatient sites and the Icahn School of Medicine at Mount Sinai. The scale helped Mount Sinai navigate the COVID-19 pandemic, in part by allowing the system to consolidate ICUs and position staff with more expertise in the right places and use them more efficiently. Davis has also been at the forefront of the move from fee-for-service medicine to value-based care and population health. Davis, a neurobiologist, previously chaired Mount Sinai’s department of psychiatry for 15 years. His research led to four of the first five Food and Drug Administration-approved treatments for Alzheimer’s disease.